Locust Wood Capital Advisers, LLC Boston Scientific Corp Transaction History

Locust Wood Capital Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$35.24 - $47.1 $65.7 Million - $87.7 Million	-1,863,004 Reduced 89.8%	211,643 $7.89 Million
Q4 2021 Jan 24, 2022	BUY	$38.07 - $44.87 $19.5 Million - $23 Million	512,706 Added 32.82%	2,074,647 $88.1 Million
Q3 2021 Oct 20, 2021	SELL	$41.23 - $45.88 $6.11 Million - $6.79 Million	-148,093 Reduced 8.66%	1,561,941 $67.8 Million
Q2 2021 Jul 26, 2021	BUY	$38.58 - $44.24 $56,018 - $64,236	1,452 Added 0.08%	1,710,034 $73.1 Million
Q1 2021 Apr 22, 2021	SELL	$35.27 - $39.67 $1.2 Million - $1.35 Million	-33,948 Reduced 1.95%	1,708,582 $66 Million
Q4 2020 Jan 25, 2021	BUY	$33.15 - $41.97 $19.8 Million - $25.1 Million	597,795 Added 52.22%	1,742,530 $62.6 Million
Q3 2020 Oct 21, 2020	BUY	$34.44 - $42.23 $2.92 Million - $3.58 Million	84,855 Added 8.01%	1,144,735 $43.7 Million
Q2 2020 Jul 21, 2020	BUY	$30.19 - $39.11 $32 Million - $41.5 Million	1,059,880 New	1,059,880 $37.2 Million

1,543

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Locust Wood Capital Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Locust Wood Capital Advisers, LLC with notifications on news.